Donate
Member Login
Mobile Buttons
Donate
Member Login
About Us
About ANZCHOG
Board of Directors
Our People
Membership
Supporters & Partners
Why childhood cancer is different
Collaborations
Equitable Pathways
Resources
Clinical Trials & Research
Clinical Trials
Research
ANZCHOG Children’s Cancer Clinical Trials Repository
CIRCAA
Annual Scientific Meeting
News & Events
News
Events
Position Statements & Guidelines
Contact Us
Last Updated | 8 April 2026
The CLOCK Trial
Preventing adverse events during paediatric cancer treatment: A multi-site hybrid randomised controlled trial of catheter lock solutions (The CLOCK trial)
External Registry
Site Status
Christchurch Hospital
Queensland Children's Hospital Monash Health Clayton Royal Children's Hospital Starship Children's Hospital
Sydney Children's Hospital
Queensland Children's Hospital
(QLD)
John Hunter Children's Hospital
(NSW)
Sydney Children's Hospital
(NSW)
Monash Health Clayton
(VIC)
Royal Children's Hospital
(VIC)
Women's and Children's Hospital
(SA)
Perth Children's Hospital
(WA)
Royal Hobart Hospital
(TAS)
Children's Hospital at Westmead
(NSW)
Starship Children's Hospital
(NZ)
Christchurch Hospital
(NZ)
Preparing to Open
Open
Temporarily Closed
Closed
Complete
Adult Sites
These sites are not monitored. Status may vary.
Diagnosis Stage
N/A
National Sponsor
University of Queensland
Open Date
10/07/2023
Conditions
All paediatric cancer types
Central vascular access device (CVAD) related adverse events
Patient Range
–
<18 years
0
50
99+
Disease Type
, Brain and Spinal (Central Nervous System) Tumours, Digestive System Tumours, Endocrine Tumours, Eye Tumours, Female genital tumours, Genetic tumour syndromes, Germ Cell Tumours, Leukaemia / Lymphoma / Blood Disorders, Head and neck tumours, Neuroblastoma and Ganglioneuroblastoma, Kidney (Renal) Tumours, Skin tumours, Soft Tissue and Bone Tumours (Sarcoma), Chest and Lung (Thoracic) Tumours
Study Type
Observational
International Sponsor
N/A
Join our newsletter
"
*
" indicates required fields
Name
This field is for validation purposes and should be left unchanged.
Full Name
*
Email
*